{"id":"W4297394691","doi":"10.3389/fmed.2022.921967","title":"Challenges in severe asthma: Do we need new drugs or new biomarkers?","year":2022,"lang":"en","type":"review","venue":"Frontiers in Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Asthma; Intensive care medicine; Disease; Biomarker; Small airways; Clinical trial; Omalizumab; Inhaled corticosteroids; Biologic Agents; Immunology; Internal medicine; Immunoglobulin E; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008359317,0.0009504966,0.005003792,0.002076153,0.00007179365,0.00001321328,0.0006140409,0.0006038643,0.004167786],"category_scores_gemma":[0.0006928138,0.0006282828,0.0004974988,0.001847221,0.0002368839,0.00009976723,0.0002188336,0.001452388,0.00004087667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008422993,"about_ca_system_score_gemma":0.003356841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001599558,"about_ca_topic_score_gemma":0.00005416977,"domain_scores_codex":[0.9950164,0.000479113,0.001480081,0.001163309,0.001064869,0.0007962561],"domain_scores_gemma":[0.9972184,0.0002974604,0.0004928623,0.001008761,0.000028778,0.0009537446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003082912,0.000107157,0.00009441107,0.009611992,0.0002272297,0.001186303,0.0008549081,4.69705e-7,3.288365e-8,0.000008909061,0.3200609,0.6675394],"study_design_scores_gemma":[0.00480435,0.000770474,0.00009237167,0.04666302,0.0008767488,0.0002596662,0.008416248,0.000005424333,4.183624e-8,0.0001279369,0.9374193,0.0005644431],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002668574,0.9827892,0.00005901672,0.005525742,0.003062353,0.001891254,0.00001912475,0.0001006802,0.006549981],"genre_scores_gemma":[0.000001800625,0.9844286,0.001078595,0.0004486375,0.002218932,0.0001293309,0.0001841734,0.0001695066,0.01134035],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.666975,"threshold_uncertainty_score":0.9996169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07115740195567312,"score_gpt":0.3382642617154771,"score_spread":0.267106859759804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}